Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Neurochem Res ; 34(3): 581-6, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18751894

RESUMO

Heart glycogen represents a store of glucosyl residues which are mobilized by the catalysis of glycogen phosphorylase (GP) and are mainly destined to serve as substrates for the generation of ATP. The brain isoform of GP (GP BB) was studied in rat heart in comparison with the muscle isoform (GP MM) to find functional analogies to the brain. Western blotting and quantitative reverse transcriptase polymerase chain reaction (RT-PCR) experiments revealed that at the protein level, but not at the mRNA level, the content of GP BB is similar in heart and brain. In contrast, GP MM is more abundant in the heart than in the brain. Immunocytochemically GP BB was colocalized with GP MM in cardiomyocytes. GP MM was also detected in interstitial cells identified as fibroblasts. The physiological role of co-expression of GP BB and GP MM in cardiomyocytes and in brain astrocytes is discussed in a comparative way.


Assuntos
Glicogênio Fosforilase Encefálica/biossíntese , Glicogênio Fosforilase Muscular/biossíntese , Miocárdio/enzimologia , Animais , Astrócitos/enzimologia , Encéfalo/enzimologia , Glicogênio Fosforilase Encefálica/genética , Glicogênio Fosforilase Muscular/genética , Immunoblotting , Isoenzimas/biossíntese , Isoenzimas/genética , Masculino , RNA Mensageiro/biossíntese , Ratos , Ratos Wistar , Reação em Cadeia da Polimerase Via Transcriptase Reversa
2.
Neurochem Res ; 33(12): 2575-82, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18338248

RESUMO

Kidney contains glycogen. Glycogen is degraded by glycogen phosphorylase (GP). This enzyme comes in three isoforms, one of which, the brain isozyme (GP BB), is known to occur in kidney. Its pattern of distribution in rat kidney was studied in comparison to that of the muscle isoform (GP MM) with the aim to see if for GP BB and GP MM there were functional similarities in brain and kidney. In immunoblotting and quantitative reverse transcriptase polymerase chain reaction (RT-PCR) experiments, both isozymes and their respective mRNAs were found in kidney homogenates. GP BB was immunocytochemically detected in collecting ducts which were identified by the marker protein aquaporin-2. GP MM was localized exclusively in interstitial cells of cortex and outer medulla. These cells were identified as fibroblasts by their expression of 5'-ectonucleotidase (cortex) or by their morphology (outer medulla). The physiological role of both isozymes is discussed in respect to local demands of energy and of proteoglycan building blocks.


Assuntos
Encéfalo/enzimologia , Glicogênio Fosforilase/metabolismo , Isoenzimas/metabolismo , Rim/enzimologia , Músculos/enzimologia , Sequência de Aminoácidos , Animais , Sequência de Bases , Primers do DNA , Eletroforese em Gel de Poliacrilamida , Glicogênio Fosforilase/genética , Imuno-Histoquímica , Isoenzimas/genética , Masculino , Dados de Sequência Molecular , RNA Mensageiro/genética , Ratos , Ratos Wistar , Reação em Cadeia da Polimerase Via Transcriptase Reversa
3.
Neurochem Res ; 32(9): 1489-98, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17406976

RESUMO

The present study investigated the role of angiotensin receptors (AT-R) in the survival and inflammatory response of astroglia upon hypoxic injury. Exposure of rat astroglial primary cultures (APC) to hypoxic conditions (HC) led to decreased viability of the cells and to a 3.5-fold increase in TNF-alpha release. AT-R type1 (AT1-R) antagonist losartan and its metabolite EXP3174 decrease the LDH release (by 36 +/- 9%; 45 +/- 6%) from APC under HC. Losartan diminished TNF-alpha release (by 40 +/- 15%) and the number of TUNEL-cells by 204 +/- 38% under HC, alone and together with angiotensin II (ATII), while EXP3174 was dependent on ATII for its effect on TNF-alpha. The AT2-R antagonist, PD123.319, did not influence the release of LDH and TNF-alpha under normoxic (NC) and HC. These data suggest that AT1-R may decrease the susceptibility of astrocytes to hypoxic injury and their propensity to release TNF-alpha. AT1-R antagonists may therefore be of therapeutic value during hypoxia-associated neurodegeneration.


Assuntos
Astrócitos/efeitos dos fármacos , Astrócitos/metabolismo , Hipóxia Celular/fisiologia , Losartan/farmacologia , Receptor Tipo 1 de Angiotensina/efeitos dos fármacos , Fator de Necrose Tumoral alfa/metabolismo , Animais , Células Cultivadas , Imidazóis/farmacologia , Ratos , Ratos Wistar , Receptor Tipo 1 de Angiotensina/biossíntese , Receptor Tipo 2 de Angiotensina/biossíntese , Tetrazóis/farmacologia
4.
J Neurochem ; 101(1): 274-88, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17394468

RESUMO

The rat ortholog of the WD40 repeat protein Wdr16 is abundantly expressed in testis and cultured ependymal cells. Low levels are found in lung and brain, respectively, while it is absent from kinocilia-free tissues. In testis and ependymal primary cultures, Wdr16 messenger RNA appears concomitantly with the messages for sperm-associated antigen 6, a kinocilia marker, and for hydin, a protein linked to ciliary function and hydrocephalus. In testis, ependyma and respiratory epithelium, the Wdr16 protein is up-regulated together with kinocilia formation. The wdr16 gene is restricted to genera in possession of kinocilia, and it is strongly conserved during evolution. The human and zebrafish proteins are identical in 62% of their aligned amino acids. On the message level, the zebrafish Wdr16 ortholog was found exclusively in kinocilia-bearing tissues by in situ hybridisation. Gene knockdown in zebrafish embryos by antisense morpholino injection resulted in severe hydrocephalus formation with unaltered ependymal morphology or ciliary beat. Wdr16 can be considered a differentiation marker of kinocilia-bearing cells. In the brain, it appears to be functionally related to water homeostasis or osmoregulation.


Assuntos
Cílios/metabolismo , Hidrocefalia/genética , Proteínas dos Microfilamentos/genética , Proteínas do Tecido Nervoso/genética , Proteínas de Peixe-Zebra/genética , Peixe-Zebra/anormalidades , Sequência de Aminoácidos , Animais , Sequência de Bases , Biomarcadores/análise , Biomarcadores/metabolismo , Células Cultivadas , Transtornos da Motilidade Ciliar/genética , Transtornos da Motilidade Ciliar/metabolismo , Transtornos da Motilidade Ciliar/fisiopatologia , Regulação para Baixo/efeitos dos fármacos , Regulação para Baixo/fisiologia , Epêndima/anormalidades , Epêndima/citologia , Epêndima/metabolismo , Evolução Molecular , Humanos , Hidrocefalia/metabolismo , Hidrocefalia/fisiopatologia , Ventrículos Laterais/anormalidades , Ventrículos Laterais/metabolismo , Ventrículos Laterais/fisiopatologia , Proteínas dos Microfilamentos/biossíntese , Proteínas dos Microfilamentos/isolamento & purificação , Dados de Sequência Molecular , Proteínas do Tecido Nervoso/biossíntese , Proteínas do Tecido Nervoso/isolamento & purificação , Oligonucleotídeos Antissenso/farmacologia , Filogenia , RNA Mensageiro/metabolismo , Ratos , Homologia de Sequência de Aminoácidos , Equilíbrio Hidroeletrolítico/genética , Equilíbrio Hidroeletrolítico/fisiologia , Proteínas de Peixe-Zebra/biossíntese , Proteínas de Peixe-Zebra/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA